Summaries of health policy coverage from major news organizations

IAVI To Appoint Two Drug Industry Executives to Top Posts

The International AIDS Vaccine Initiative on Wednesday said it plans to appoint two pharmaceutical industry executives to top scientific and management jobs, the Wall Street Journal reports. As of June 1, Stephen Udem, vice president of exploratory vaccine discovery research at Wyeth Vaccines Research, a unit of Wyeth, will serve as IAVI's senior vice president of vaccine development. Udem -- who will be replacing Emilio Emini -- also will serve as IAVI's chief scientific officer. In addition, John McGoldrick -- executive vice president of Bristol-Myers Squibb in charge of law, government affairs, philanthropy and global policy -- will be appointed IAVI's senior vice president of external strategy development, a new position that will focus on raising funds and managing resources. McGoldrick begins his new position May 30. According to the Journal, IAVI has "helped to put six AIDS vaccine products into human tests around the world" (Chase, Wall Street Journal, 5/10).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.